Secretory Component (polymeric Immunoglobulin Receptor) As an Intrinsic Inhibitor of Biological Functions of Interferon Gamma in Keratinocytes

Overview

Journal Arch Dermatol Res

Specialty Dermatology

Date 1995 Jan 1

PMID 7487140

Citations 2

Authors

Y Nihei

K Maruyama

J Z Zhang

K Kobayashi

F Kaneko

Affiliations

Soon will be listed here.

Abstract

Secretory component (SC) acts as a transmembrane polymeric immunoglobulin receptor of epithelial cells and is known to bind to polymeric IgA and to contribute to the secretion of secretory IgA (sIgA). We describe a new biological function for free SC (FSC) by which the expression of intercellular adhesion molecule-1 (ICAM-1) and HLA-DR induced by interferon gamma (IFN gamma) is inhibited in human keratinocytes. This activity coincided with suppression of adenosine cyclic 3,5-monophosphate (cyclic AMP) production in keratinocytes. Keratinocytes produced SC after stimulation with IFN gamma and this production was suppressed by the addition of H-7 or propranolol. The addition of propranolol resulted in prolongation of ICAM-1 expression on keratinocytes induced by IFN gamma. These results suggest that endogenously produced SC, as well as exogenously added FSC, acts as an inhibitor of IFN gamma. Therefore, our results suggest that SC plays an antiinflammatory role in the pathogenesis of inflammatory skin diseases via inhibition in keratinocytes of IFN gamma induced expression of ICAM-1 and HLA-DR.

Citing Articles

The Effect of Atopic Dermatitis and Diet on the Skin Transcriptome in Staffordshire Bull Terriers.

Anturaniemi J, Zaldivar-Lopez S, Savelkoul H, Elo K, Hielm-Bjorkman A Front Vet Sci. 2020; 7:552251.

PMID: 33178726 PMC: 7596200. DOI: 10.3389/fvets.2020.552251.

Activation of epithelial and myoepithelial cells in the salivary glands of patients with Sjögren's syndrome: high expression of intercellular adhesion molecule-1 (ICAM.1) in biopsy specimens and cultured cells.

Kapsogeorgou E, Dimitriou I, Moutsopoulos H, Manoussakis M Clin Exp Immunol. 2001; 124(1):126-33.

PMID: 11359451 PMC: 1906035. DOI: 10.1046/j.1365-2249.2001.01500.x.

References

Bouillon M, Fortier M, Boulianne R, Audette M . Biphasic effect of cAMP-elevating agents on ICAM-1 expression stimulated by retinoic acid and interferon gamma. Int J Cancer. 1992; 50(2):281-8. DOI: 10.1002/ijc.2910500219. View

Nickoloff B, Mitra R . Intraepidermal psoriatic cytokine network involves gamma interferon, transforming growth factor-alpha, and their cell surface receptors: dysregulation rather than deficiency. J Invest Dermatol. 1992; 99(6):882-3. DOI: 10.1111/1523-1747.ep12614874. View

Rivas J, Ullrich S . Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratinocyte-derived IL-10. J Immunol. 1992; 149(12):3865-71. View

Takematsu H, Tagami H . Quantification of chemotactic peptides (C5a anaphylatoxin and IL-8) in psoriatic lesional skin. Arch Dermatol. 1993; 129(1):74-80. View

Wilson T, Christie D . Gravidin, an endogenous inhibitor of phospholipase A2 activity, is a secretory component of IgA. Biochem Biophys Res Commun. 1991; 176(1):447-52. DOI: 10.1016/0006-291x(91)90944-3. View

Huff J . Epithelial polymeric immunoglobulin receptors. J Invest Dermatol. 1990; 94(6 Suppl):74S-78S. DOI: 10.1111/1523-1747.ep12875160. View

Sollid L, Kvale D, Brandtzaeg P, Markussen G, Thorsby E . Interferon-gamma enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins. J Immunol. 1987; 138(12):4303-6. View

Lucisano Valim Y, LACHMANN P . The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions. Clin Exp Immunol. 1991; 84(1):1-8. PMC: 1535367. DOI: 10.1111/j.1365-2249.1991.tb08115.x. View

Kusama K, Takahashi T, Asano M, Iwase T, Saito T, Nagasaki Y . Murine monoclonal antibody to secretory component. Shika Kiso Igakkai Zasshi. 1989; 31(4):471-3. DOI: 10.2330/joralbiosci1965.31.471. View

10.

Kaneko F, Gushiken H, Kawagishi I, Miura Y, Kobayashi K, Konno T . Analysis of immunological responses in psoriatic lesions: (1) immunopathological studies on psoriatic lesions. J Invest Dermatol. 1980; 75(5):436-9. DOI: 10.1111/1523-1747.ep12524088. View

11.

Mostov K . The polymeric immunoglobulin receptor. Semin Cell Biol. 1991; 2(6):411-8. View

12.

Kvale D, Lovhaug D, Sollid L, Brandtzaeg P . Tumor necrosis factor-alpha up-regulates expression of secretory component, the epithelial receptor for polymeric Ig. J Immunol. 1988; 140(9):3086-9. View

13.

Kaneko F, Kawagishi I, Miura Y, Kobayashi K . Secretory IgA in skin and the adjacent mucous membranes. J Dermatol. 1982; 9(2):99-106. DOI: 10.1111/j.1346-8138.1982.tb02610.x. View

14.

Phillips J, Everson M, Moldoveanu Z, Lue C, Mestecky J . Synergistic effect of IL-4 and IFN-gamma on the expression of polymeric Ig receptor (secretory component) and IgA binding by human epithelial cells. J Immunol. 1990; 145(6):1740-4. View

15.

Steinkraus V, Steinfath M, Mensing H . Beta-adrenergic blocking drugs and psoriasis. J Am Acad Dermatol. 1992; 27(2 Pt 1):266-7. DOI: 10.1016/s0190-9622(08)80738-4. View

16.

Nickoloff B . The cytokine network in psoriasis. Arch Dermatol. 1991; 127(6):871-84. View

17.

Krajci P, Kvale D, Tasken K, Brandtzaeg P . Molecular cloning and exon-intron mapping of the gene encoding human transmembrane secretory component (the poly-Ig receptor). Eur J Immunol. 1992; 22(9):2309-15. DOI: 10.1002/eji.1830220920. View

18.

Fernandez-Botran R . Soluble cytokine receptors: their role in immunoregulation. FASEB J. 1991; 5(11):2567-74. DOI: 10.1096/fasebj.5.11.1868981. View

19.

Wiley 3rd H, Weinstein G . Abnormal proliferation of uninvolved psoriatic epidermis: differential induction by saline, propranolol, and tape stripping in vivo. J Invest Dermatol. 1979; 73(6):545-7. DOI: 10.1111/1523-1747.ep12541532. View

20.

Maruyama K, Zhang J, Nihei Y, Ono I, Kaneko F . Regulatory effects of antipsoriatic agents on interleukin-1 alpha production by human keratinocytes stimulated with gamma interferon in vitro. Skin Pharmacol. 1995; 8(1-2):41-8. DOI: 10.1159/000211329. View